Chemocentryx Inc (CCXI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2022 | 03-2022 | 12-2021 | 09-2021 | 06-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 44,396 | 40,577 | 49,978 | 93,726 | 77,205 |
| Marketable Securities | 284,219 | 300,024 | 214,514 | 175,701 | 235,399 |
| Receivables | 4,946 | 2,810 | 454 | 20,057 | 171 |
| Inventories | 5,474 | 2,897 | 851 | N/A | N/A |
| TOTAL | $345,172 | $351,632 | $269,177 | $293,383 | $317,133 |
| Non-Current Assets | |||||
| PPE Net | 30,856 | 31,482 | 32,269 | 33,002 | 33,781 |
| Investments And Advances | 17,551 | 31,235 | 97,856 | 102,030 | 90,028 |
| Other Non-Current Assets | 25,811 | 26,104 | 26,350 | 26,430 | 26,730 |
| TOTAL | $74,218 | $88,821 | $156,475 | $161,462 | $150,539 |
| Total Assets | $419,390 | $440,453 | $425,652 | $454,845 | $467,672 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 19,720 | 19,128 | 18,920 | 14,013 | 12,984 |
| Accounts payable and accrued liabilities | 7,592 | 5,423 | 6,746 | 4,414 | 11,094 |
| Accrued Expenses | 27,744 | 25,547 | 26,358 | 25,984 | 20,686 |
| TOTAL | $76,078 | $68,807 | $63,017 | $60,029 | $55,379 |
| Non-Current Liabilities | |||||
| Long Term Debt | 4,005 | 4,554 | 4,715 | 9,560 | 11,566 |
| Deferred Revenues | 21,022 | 18,709 | 10,993 | 15,618 | 10,615 |
| Other Non-Current Liabilities | 45,478 | 46,279 | 47,028 | 47,939 | 46,349 |
| TOTAL | $106,782 | $112,927 | $76,515 | $78,922 | $82,023 |
| Total Liabilities | $182,860 | $181,734 | $139,532 | $138,951 | $137,402 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 71,356 | 71,193 | 70,841 | 70,031 | 69,904 |
| Common Shares | 71 | 71 | 70 | 70 | 70 |
| Retained earnings | -687,356 | -655,705 | -617,097 | -576,569 | -554,262 |
| Other shareholders' equity | -2,326 | -1,871 | -499 | -53 | -97 |
| TOTAL | $236,530 | $258,719 | $286,120 | $315,894 | $330,270 |
| Total Liabilities And Equity | $419,390 | $440,453 | $425,652 | $454,845 | $467,672 |